Fresenius

 

404

Page not found

It seems that you we're looking for something. Maybe you wanted to find out who we are, browse our products, contact us or catch up on the latest news.

Social Media Guidelines (Teaser)

All

Business segments

Fresenius Fresenius Medical Care Fresenius Kabi Fresenius Helios Fresenius Vamed

Topics

Financial Reporting Corporate Actions Financing M&A / Joint Ventures Other

Time span

News 0 - 0 of 0

Open order service

Ad Hoc News

Contact

Nick Stone

Senior Vice President Investor Relations
Head of Investor Relations
T: +49 (0) 6172 608-97033
nick.stone@fresenius.com

Information & Order Service

Stay informed about the latest news and developments at our Group by subscribing to our Investor News and/or to the Fresenius Brief News. These services are free of charge and may be cancelled at any time.

Please send me via email
Fresenius Brief News
Fresenius Investor News
Do you have other questions or need any more information?
Please send us a message:

By submitting, you agree to our privacy policy.
To unsubscribe to these services, please send a brief e-mail to ir-fre@fresenius.com or call +49 (0) 6172 608-2470.

All

Events

Financial Reporting Health Care Media

Time span

All

Business segments

Fresenius Fresenius Medical Care Fresenius Kabi Fresenius Helios Fresenius Vamed

Topics

Business & Finance Locations Medicine & Research

Time span

News 0 - 0 of 0

Open order service

Order Service News

Would you like to be included on our distribution list for media information? We would be happy to provide you with our latest press releases and brief news by e-mail. This service is free of charge and may be cancelled at any time.

News Type

Group Figures

Alternative Performance Measures Interactive Tool

Strategy & Outlook

Goals and Strategy Financial Performance Indicators Group Structure Outlook
Subscribe to